Editorial Open Access
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2019.24.48.1900720
Like 0
Access full text
Article
-
Influenza imprinting in childhood and the influence on vaccine response later in life
- Alyson A Kelvin1,2 , Maria Zambon3
-
View Affiliations Hide AffiliationsAffiliations: 1 Department of Pediatrics, Division of Infectious Disease, Faculty of Medicine, Dalhousie University, Halifax, Canada 2 Canadian Centre for Vaccinology, IWK Health Centre, Halifax, Canada 3 National Infection Service, Public Health England, London, United KingdomAlyson A Kelvinakelvin dal.ca
-
View Citation Hide Citation
Citation style for this article: Kelvin Alyson A, Zambon Maria. Influenza imprinting in childhood and the influence on vaccine response later in life . Euro Surveill. 2019;24(48):pii=1900720. https://doi.org/10.2807/1560-7917.ES.2019.24.48.1900720 Received: 24 Nov 2019; Accepted: 27 Nov 2019
- Previous Article
- Table of Contents
- Next Article
Preview this article:
Influenza imprinting in childhood and the influence on vaccine response later in life, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/eurosurveillance/24/48/eurosurv-24-48-1-1.gifThere is no abstract available.
Article metrics loading...
/content/10.2807/1560-7917.ES.2019.24.48.1900720
2019-11-28
2024-12-10
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2019.24.48.1900720
Full text loading...
/deliver/fulltext/eurosurveillance/24/48/eurosurv-24-48-1.html?itemId=/content/10.2807/1560-7917.ES.2019.24.48.1900720&mimeType=html&fmt=ahah
References
-
Francis ME, King ML, Kelvin AA. Back to the Future for Influenza Preimmunity-Looking Back at Influenza Virus History to Infer the Outcome of Future Infections. Viruses. 2019;11(2):E122. https://doi.org/10.3390/v11020122 PMID: 30704019
-
Gostic KM, Ambrose M, Worobey M, Lloyd-Smith JO. Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting. Science. 2016;354(6313):722-6. https://doi.org/10.1126/science.aag1322 PMID: 27846599
-
Skowronski DM, Sabaiduc S, Leir S, Rose C, Zou M, Murti M, et al. Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV). Euro Surveill. 2019;24(46). https://doi.org/10.2807/1560-7917.ES.2019.24.46.1900585
-
Kissling E, Pozo F, Buda S, Vilcu AM, Gherasim A, Brytting M, et al. Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohort. Euro Surveill. 2019;24(48):1900604.
-
Francis TJ. On the Doctrine of Original Antigenic Sin. Proc Am Philos Soc. 1960;104:572-8.
-
Monto AS, Malosh RE, Petrie JG, Martin ET. The doctrine of original antigenic sin: separating good from evil. J Infect Dis. 2017;215(12):1782-8. https://doi.org/10.1093/infdis/jix173 PMID: 28398521
-
Hoskins TW, Davies JR, Smith AJ, Miller CL, Allchin A. Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ’s Hospital. Lancet. 1979;1(8106):33-5. https://doi.org/10.1016/S0140-6736(79)90468-9 PMID: 83475
-
Worobey M, Han GZ, Rambaut A. Genesis and pathogenesis of the 1918 pandemic H1N1 influenza A virus. Proc Natl Acad Sci USA. 2014;111(22):8107-12. https://doi.org/10.1073/pnas.1324197111 PMID: 24778238
-
Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361(20):1945-52. https://doi.org/10.1056/NEJMoa0906453 PMID: 19745214
-
Andrews SF, Huang Y, Kaur K, Popova LI, Ho IY, Pauli NT, et al. Immune history profoundly affects broadly protective B cell responses to influenza. Sci Transl Med. 2015;7(316):316ra192. https://doi.org/10.1126/scitranslmed.aad0522 PMID: 26631631
-
Krammer F. The human antibody response to influenza A virus infection and vaccination. Nat Rev Immunol. 2019;19(6):383-97. https://doi.org/10.1038/s41577-019-0143-6 PMID: 30837674
-
Yu X, Tsibane T, McGraw PA, House FS, Keefer CJ, Hicar MD, et al. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature. 2008;455(7212):532-6. https://doi.org/10.1038/nature07231 PMID: 18716625
-
Karageorgopoulos DE, Vouloumanou EK, Korbila IP, Kapaskelis A, Falagas ME. Age distribution of cases of 2009 (H1N1) pandemic influenza in comparison with seasonal influenza. PLoS One. 2011;6(7):e21690. https://doi.org/10.1371/journal.pone.0021690 PMID: 21747947
-
Miller MS, Tsibane T, Krammer F, Hai R, Rahmat S, Basler CF, et al. 1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans. J Infect Dis. 2013;207(1):98-105. https://doi.org/10.1093/infdis/jis652 PMID: 23087428
-
Davenport FM, Hennessy AV. Predetermination by infection and by vaccination of antibody response to influenza virus vaccines. J Exp Med. 1957;106(6):835-50. https://doi.org/10.1084/jem.106.6.835 PMID: 13481247
-
Skowronski DM, Chambers C, De Serres G, Sabaiduc S, Winter AL, Dickinson JA, et al. Serial vaccination and the antigenic distance hypothesis: effects on influenza vaccine effectiveness during A(H3N2) epidemics in canada, 2010-2011 to 2014-2015. J Infect Dis. 2017;215(7):1059-99. https://doi.org/10.1093/infdis/jix074 PMID: 28180277
-
Zost SJ, Parkhouse K, Gumina ME, Kim K, Diaz Perez S, Wilson PC, et al. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc Natl Acad Sci USA. 2017;114(47):12578-83. https://doi.org/10.1073/pnas.1712377114 PMID: 29109276
-
Francis ME, McNeil M, Dawe NJ, Foley MK, King ML, Ross TM, et al. Historical H1N1 influenza virus imprinting increases vaccine protection by influencing the activity and sustained production of antibodies elicited at vaccination in ferrets. Vaccines (Basel). 2019;7(4):133. https://doi.org/10.3390/vaccines7040133 PMID: 31569351
-
Miller MS, Gardner TJ, Krammer F, Aguado LC, Tortorella D, Basler CF, et al. Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis. Sci Transl Med. 2013;5(198):198ra107. https://doi.org/10.1126/scitranslmed.3006637 PMID: 23946196
-
Henry C, Zheng NY, Huang M, Cabanov A, Rojas KT, Kaur K, et al. influenza virus vaccination elicits poorly adapted B cell responses in elderly individuals. Cell Host Microbe. 2019;25(3):357-366.e6. https://doi.org/10.1016/j.chom.2019.01.002 PMID: 30795982
-
Lee J, Paparoditis P, Horton AP, Fruhwirth A, McDaniel JR, Jung J, et al. Persistent antibody clonotypes dominate the serum response to influenza over multiple years and repeated vaccinations. Cell Host Microbe. 2019;25(3):367-76e5. PMID: 30795982
-
Bouvier NM, Lowen AC. Animal models for influenza virus pathogenesis and transmission. Viruses. 2010;2(8):1530-63. https://doi.org/10.3390/v20801530 PMID: 21442033
-
Kosikova M, Li L, Radvak P, Ye Z, Wan XF, Xie H. Imprinting of repeated influenza A/H3 exposures on antibody quantity and antibody quality: implications for seasonal vaccine strain selection and vaccine performance. Clin Infect Dis. 2018;67(10):1523-32. https://doi.org/10.1093/cid/ciy327 PMID: 29672713
-
Allen JD, Jang H, DiNapoli J, Kleanthous H, Ross TM. Elicitation of protective antibodies against 20 years of future H3N2 cocirculating influenza virus variants in ferrets preimmune to historical H3N2 influenza viruses. J Virol. 2019;93(3):e00946-18. https://doi.org/10.1128/JVI.00946-18 PMID: 30429350
-
Jang H, Ross TM. Preexisting influenza specific immunity and vaccine effectiveness. Expert Rev Vaccines. 2019;18(10):1043-51. https://doi.org/10.1080/14760584.2019.1675519 PMID: 31575308
-
Andrews SF, Kaur K, Pauli NT, Huang M, Huang Y, Wilson PC. High preexisting serological antibody levels correlate with diversification of the influenza vaccine response. J Virol. 2015;89(6):3308-17. https://doi.org/10.1128/JVI.02871-14 PMID: 25589639
-
Lessler J, Riley S, Read JM, Wang S, Zhu H, Smith GJ, et al. Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China. PLoS Pathog. 2012;8(7):e1002802. https://doi.org/10.1371/journal.ppat.1002802 PMID: 22829765
-
Flannery B, Kondor RJG, Chung JR, Gaglani M, Reis M, Zimmerman RK, et al. Spread of antigenically drifted influenza A(H3N2) viruses and vaccine effectiveness in the United States during the 2018-2019 season. J Infect Dis. 2019;jiz543. https://doi.org/10.1093/infdis/jiz543 PMID: 31665373
-
Advisory Committee on Immunization Practices (ACIP). ACIP live meeting archive – June 2019. Agency updates; influenza vaccines. Atlanta: Centers for Disease Control and Prevention; 2019. Available from: https://www.cdc.gov/flu/weekly/weeklyarchives2018-2019/Week18.htm
Influenza imprinting in childhood and the influence on vaccine response later in life
<p class="citation">
<span>Citation style for this article:</span>
<span class="meta-value authors">
<a href="/search?value1=Alyson+A+Kelvin&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Kelvin Alyson A</a>,
<a href="/search?value1=Maria+Zambon&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Zambon Maria</a></span>.
Influenza imprinting in childhood and the influence on vaccine response later in life .
<a href="/content/ecdc">Euro Surveill.</a> 2019;24(48):pii=1900720.
<a href="https://doi.org/10.2807/1560-7917.ES.2019.24.48.1900720" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2019.24.48.1900720</a>
<span class="ES_Article_citation">
<span class="generated">Received</span>: 24 Nov 2019;
<span class="generated">Accepted</span>: 27 Nov 2019
</span>
</p>
/content/10.2807/1560-7917.ES.2019.24.48.1900720
/content/10.2807/1560-7917.ES.2019.24.48.1900720
Data & Media loading...
Submit comment
Close
Comment moderation successfully completed